We serve Chemical Name:3-(2-bromopyridin-3-yl)-3-oxopropanenitrile CAS:887593-99-9 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:3-(2-bromopyridin-3-yl)-3-oxopropanenitrile
CAS.NO:887593-99-9
Synonyms:3-(2-BROMO-PYRIDIN-3-YL)-3-OXO-PROPIONITRILE;3-Pyridinepropanenitrile,2-bromo-b-oxo;2-bromo–oxo-3-Pyridinepropanenitrile
Molecular Formula:C8H5BrN2O
Molecular Weight:225.04200
HS Code:
Physical and Chemical Properties:
Melting point:N/A
Boiling point:408.545ºC at 760 mmHg
Density:1.604g/cm3
Index of Refraction:1.579
PSA:53.75000
Exact Mass:223.95900
LogP:1.94048
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 3-(2-BROMO-PYRIDIN-3-YL)-3-OXO-PROPIONITRILE chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,2-bromo–oxo-3-Pyridinepropanenitrile physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,3-(2-BROMO-PYRIDIN-3-YL)-3-OXO-PROPIONITRILE Use and application,3-(2-BROMO-PYRIDIN-3-YL)-3-OXO-PROPIONITRILE technical grade,usp/ep/jp grade.
Related News: “We welcome a formal review into the interactions between the FDA and Biogen on the path to the approval of aducanumab,” Sandrock said. “A better understanding of the facts is good for everyone involved to assure confidence in both the therapy and the process by which it was approved as we prioritize the issues that affect patients.” 2-[4-Chloro-2-(2-hydroxy-naphthalen-1-ylazo)-phenylsulfanyl]-benzoic acid methyl ester manufacturers The role of a trusted contract development and manufacturing organization (CDMO), with long-standing record of regulatory compliance and efficient project management, can help tremendously in reduced time and costs for the early phase development and commercialization of small molecule active pharmaceutical ingredients (APIs) in the pharmaceutical industry, according to experts. [W(CO)2(dppm)(1-3:5,6-η-C8H11)][BF4] suppliers After the IPO, he now owns a 53% stake, worth $3.1 billion, plus roughly $100 million in cash and other investments, including a winery in northeastern Italy. His sons Franco and Marco (the company’s vice chairman) each own 12% stakes worth about $730 million apiece. 6-(3-azidopropyl)-5,6-dihydro-8,9-methylenedioxy-5,11-dioxo-11H-indeno[1,2-c]isoquinoline vendor & factory.
